Entheon Biomedical (XCNQ:ENBI) EPS (Basic) : C$-0.04 (TTM As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical EPS (Basic)?

Entheon Biomedical's basic earnings per share (Basic EPS) for the three months ended in Feb. 2024 was C$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.04.

Entheon Biomedical's EPS (Diluted) for the three months ended in Feb. 2024 was C$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.04.

Entheon Biomedical's EPS without NRI for the three months ended in Feb. 2024 was C$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2024 was -0.05.

During the past 3 years, the average EPS without NRI Growth Rate was 40.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Entheon Biomedical's highest 3-Year average EPS without NRI Growth Rate was 40.30% per year. The lowest was -263.40% per year. And the median was -31.15% per year.

Entheon Biomedical EPS (Basic) Historical Data

The historical data trend for Entheon Biomedical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical EPS (Basic) Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

EPS (Basic)

Get a 7-Day Free Trial

-0.39

-0.24

-1.60

-1.44

-0.05

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EPS (Basic)	Get a 7-Day Free Trial															-0.02	-0.01	-0.02	-0.01	-0.01

Entheon Biomedical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Entheon Biomedical's Basic EPS for the fiscal year that ended in Nov. 2023 is calculated as

Basic EPS (A: Nov. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.3	-	0)	/	5.909
	=	-0.05

Entheon Biomedical's Basic EPS for the quarter that ended in Feb. 2024 is calculated as

Basic EPS (Q: Feb. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.075	-	0)	/	5.909
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.04

Entheon Biomedical (XCNQ:ENBI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Entheon Biomedical EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Executives

Brian Jahns

Senior Officer

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines